chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: M
Vaccine: FLU4
Symptoms: Dermatitis acneiform, Lymphadenopathy, Rash
Clinical narrative: Rash-pimple like to affected arm, in clusters started 2 days after injection. Spread to R chest and R back on affected side. Axillary lymph node swelling started approx 1 week after administration. Given antibiotics and prednisone to clear.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Swelling face
Clinical narrative: right side of face is swollen.
Age: 63.0
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Urticaria
Clinical narrative: Hives began day after immunization on bilateral arms. Topical Benadryl did not clear symptoms. Started on Zyrtec consistently two times daily along with oral Benadryl daily, will follow up with Dr next week if rash does not clear on its own.
Age: 73.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: Patient stated after the vaccine. The site where she got the vaccine was hot and red and warm to the touch. The redness was all over the site where she got the vaccine. The doctor seen her on the 4 and gave her some antibiotic thinking it could be due to celulitis.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Cellulitis, Injection site erythema, Injection site pain, Injection site vesicles, Injection site warmth
Clinical narrative: Patient developed erythema, warmth, pain at the injection site the day after injection, increased 2 days after injection with development of superficial blisters.   diagnosed with early cellulitis and Augmentin 875-125 mg prescribed twice a day for 10 days.
Age: 64.0
Sex: M
Vaccine: FLU4
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received the high dose formulation but he is only 64, he did not have any adverse effects
Age: 35.0
Sex: F
Vaccine: HPV9
Symptoms: Injected limb mobility decreased, Injection site pain, Injection site swelling
Clinical narrative: Pt called to complain of pain and swelling at injection site and she is unable to raise her arm above her head.
Age: 24.0
Sex: F
Vaccine: FLU4
Symptoms: Pruritus, Rash
Clinical narrative: Patient  discharged from clinic . Patient came back 30 minutes later stated she had rash and itching . Patients assessed for 1 hr . Vitals assessed x 1 hr .within normal ranges. Patient administered Benadryl per provider order and provider sent prescription for steriods to pharmacy . Patient denied sob, chest pain before leaving and stated itching was better.
Age: 1.92
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: The single dose vial is labeled 0.25 mL, a pediatric dose is 0.25 mL, but the vial contains 0.5 mL of vaccine. The whole vial was drawn and administered to the patient.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Headache, Impaired driving ability, Nausea
Clinical narrative: Very dizzy, have to hold on to things to balance myself, have vertigo with mild headache and nausea. Vertigo is worse  in darkness. It's been 4 days since I've had dizziness with vertigo where I have to hold onto things to balance myself, hopefully this condition will go away in a few days. I am not able to do too much being dizzy all of the time.  am taking extra Vitamin D, extra Iron and Motion Sickness pills. I am doing self care, too dizzy to drive or go to the doctor
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Very dizzy, have to hold on to things to balance myself, have vertigo with mild headache and nausea. Vertigo is worse  in darkness. It's been 4 days since I've had dizziness with vertigo where I have to hold onto things to balance myself, hopefully this condition will go away in a few days. I am not able to do too much being dizzy all of the time.  am taking extra Vitamin D, extra Iron and Motion Sickness pills. I am doing self care, too dizzy to drive or go to the doctor
Age: 33.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Feeling cold, Flushing, Headache, Malaise
Clinical narrative: Light-headed, dizziness, feeling of malaise, and flush which lasted about 15 minutes followed by a headache and feeling of coldness.
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Feeling abnormal, Feeling drunk, Somnolence
Clinical narrative: APPROX 5-10 MINS LATER AFTER ADMINISTRATION, EXPERIENCED LIGHTHEADNESS, DIZZINESS, FEELING OF MALIASE, GROGGINESS, THEN  15 MINS LATER THEN DRUNKINESS FEELING WHICH PERSISTED FOR 45 MINS.  BACK TO BASELINE 1HR 15 MINS AFTER INJECTION
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder, Tenderness
Clinical narrative: I know this has been 2 years since I received my second vaccine of Moderna in May of 2021; however, I am now concerned since it?s been so long. I still have a lot of soreness on my left arm when I touch the area where I received my second vaccine. It is sore enough for it to be uncomfortable for me to sleep on my left side. I just wanted to report this to have on file. I contacted and they advised me to report this. Thank you!
Age: 61.0
Sex: F
Vaccine: FLU4
Symptoms: Blood pressure increased, Heart rate increased, Paraesthesia oral, Throat tightness
Clinical narrative: I just injection- within an hour my throat started getting tight- but not uncomfortable .  Approximately an hour later my throat became tighter - the RN on site took my blood pressure and pulse - it was slightly elevated based on my normal but not "high".  I decided to leave within the hour and get benadryl and pepcid based on her instructions.  While driving home my tongue became tingly . I took the benadryl and pepcid and within 30 minutes all symptoms disappeared.
Age: 80.0
Sex: M
Vaccine: FLU4
Symptoms: Headache, Neutropenia, Peripheral swelling, Pyrexia, White blood cell count decreased
Clinical narrative: Headache Swelling of hands and feet low grade fever neutropenia
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness
Clinical narrative: Was very dizzy 2 days after getting the COVID shot and was dizzy for 3 days. Had to be very careful getting up to keep from losing my balance.
Age: 42.0
Sex: F
Vaccine: UNK
Symptoms: Pain, Swelling
Clinical narrative: swelling and severe pain. went to urgent care and received prednisone and pain medication. swelling and pain subsided about 30 hours after.
Age: 0.17
Sex: M
Vaccine: MMR
Symptoms: No adverse event, Product administration error, Wrong product administered
Clinical narrative: Wrong vaccination administered to a pediatric patient due to employee error. Patients mother has reported no current symptoms.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Heart rate increased, Muscle contracture, Syncope
Clinical narrative: PATIENT LIGHTHEADED, FAINTED (~2 SECONDS).  SYSTEMIC MUSCLE CONTRACTIONS AND DYSPNEA LASTING 30 MINUTES ATER REGAINING CONCIOUSNESS.  BP AND HEART RATE ELEVATED BUT DECREASED WITH TIME. NO MEDICAL INTERVENTION REQUIRED
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: I accidentally give the covid-19 vaccine (6month old-4yr old dose) patient is 8yr old on his left arm last 10/07/2023 9:50am.  Patient doesn't have any symptoms.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 73.0
Sex: F
Vaccine: PNC20
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Fever to 101.4, chills body aches, fatigue for 24 hours.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Syringe issue
Clinical narrative: No adverse event; however, faulty BD Integra syringe/needle combo. Vaccine was pulled up appropriately. Upon injection, an unknown amount of vaccine was injected into patient's arm. Most of vaccine fell directly out of syringe and onto the top of patient's arm.   Vaccine was redrawn from a new vial and re-administered to the patient per CDC guidelines.   Faulty syringe information: Lot - 0002373; Exp - 12/31/24
Age: 4.0
Sex: F
Vaccine: IPV
Symptoms: Decreased appetite, Disorganised speech, Dysphagia, Generalised tonic-clonic seizure, Immune-mediated neurological disorder
Clinical narrative: Had a grandmal seizure at 755 AM next day 9/26/23. Lasted 1.5 minutes. No fever. Post-ictal for 45 minutes.  Gargled speech since the day of vaccine. Decreased appetite. More quiet. Wednesday (9/27/23) evening 6 PM, fever x 4 days. Had vomiting. Had trouble swallowing. Evaluated at Speech evaluation now at 26 months. Able to walk.  Followed by Immunologist and Infectious Disease specialist. Immune mediated neurological response from Pediatric Neurologist.
Age: 4.0
Sex: F
Vaccine: IPV
Symptoms: Postictal state, Vomiting
Clinical narrative: Had a grandmal seizure at 755 AM next day 9/26/23. Lasted 1.5 minutes. No fever. Post-ictal for 45 minutes.  Gargled speech since the day of vaccine. Decreased appetite. More quiet. Wednesday (9/27/23) evening 6 PM, fever x 4 days. Had vomiting. Had trouble swallowing. Evaluated at Speech evaluation now at 26 months. Able to walk.  Followed by Immunologist and Infectious Disease specialist. Immune mediated neurological response from Pediatric Neurologist.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Insomnia, Mobility decreased
Clinical narrative: This was my 5th COVID vaccine.  Symptoms began @11 hours after injection on 12 October. Fever 101F, joint pain, fatigue.  Took 500mg acetominophen and went to bed at 2200h.  Experienced insomnia -- couldn't sleep for more than 2 hours at a time.  The next morning (Friday 13 October)  I had the usual achy joints and profound tiredness.  This persisted through Saturday, 14 October.    Saturday night just before midnight my lower back began to ache -- very much like sciatic nerve pain, but just in the lower back area just above the buttocks.  When I awoke on Sunday morning (15 October) I was unable to bend over -- the nerve pain was intense.  I took 400mg naproxen at 0830, and another 200mg naproxen at 1445h.    Monday morning 16 October the nerve pain was still present and again I took 400mg naproxen to see if it would help.  Tuesday morning 17 October  was a little better, and I did not take any pain relief medication all day.  Wednesday morning (today, 18 October) the pain was back, but it was less like sciatica and more like a lower back muscle pain.    As of 1629h 18 October, it has not subsided.  Spikevax was very different from any of the other COVID vaccines I have had. I got the usual fever, joint pain and exhaustion, but   I did not get the usual lymph node swelling (collarbone and underarm) and I had insomnia.   The back pain, I must say, is alarming as I can find no cause for it other than vaccine related.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pyrexia
Clinical narrative: This was my 5th COVID vaccine.  Symptoms began @11 hours after injection on 12 October. Fever 101F, joint pain, fatigue.  Took 500mg acetominophen and went to bed at 2200h.  Experienced insomnia -- couldn't sleep for more than 2 hours at a time.  The next morning (Friday 13 October)  I had the usual achy joints and profound tiredness.  This persisted through Saturday, 14 October.    Saturday night just before midnight my lower back began to ache -- very much like sciatic nerve pain, but just in the lower back area just above the buttocks.  When I awoke on Sunday morning (15 October) I was unable to bend over -- the nerve pain was intense.  I took 400mg naproxen at 0830, and another 200mg naproxen at 1445h.    Monday morning 16 October the nerve pain was still present and again I took 400mg naproxen to see if it would help.  Tuesday morning 17 October  was a little better, and I did not take any pain relief medication all day.  Wednesday morning (today, 18 October) the pain was back, but it was less like sciatica and more like a lower back muscle pain.    As of 1629h 18 October, it has not subsided.  Spikevax was very different from any of the other COVID vaccines I have had. I got the usual fever, joint pain and exhaustion, but   I did not get the usual lymph node swelling (collarbone and underarm) and I had insomnia.   The back pain, I must say, is alarming as I can find no cause for it other than vaccine related.
Age: 4.0
Sex: F
Vaccine: IPV
Symptoms: Balance disorder, Condition aggravated, Gait inability, Nystagmus, Pyrexia
Clinical narrative: On 9/27/23: Unable to walk for 5 days due to vertigo and nystagmus. Still will balance issues. Fever x 5 days. Treated with amoxicillin, fever resolved.
Age: 4.0
Sex: F
Vaccine: IPV
Symptoms: Vertigo
Clinical narrative: On 9/27/23: Unable to walk for 5 days due to vertigo and nystagmus. Still will balance issues. Fever x 5 days. Treated with amoxicillin, fever resolved.
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Erythema, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Redness swelling and warmth with 4 hours. Extended 8in x3 in (down arm past elbow to forearm).  Hives/welts present and painful and itching still 5 days later
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Injection site warmth, Peripheral swelling, Skin warm, Urticaria
Clinical narrative: Redness swelling and warmth with 4 hours. Extended 8in x3 in (down arm past elbow to forearm).  Hives/welts present and painful and itching still 5 days later
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Patient got spikevax on 10-14-23 IM in the left arm. Two days later the patient started having intermittent sharp pain lasting up to 30 seconds at and around the injection site. She did not take anything to treat the pain. She did not check for any redness, heat or swelling. She still had the bandaid on from the vaccine administraion. We went to the vaccine room and she removed the bandaid. No redness, swelling or heat was found. I encouraged the patient to continue to moniter her arm and seek medical attention if the pain worsened or if it started showing signs of infection. She agreed.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 75.0
Sex: F
Vaccine: RSV
Symptoms: Myalgia
Clinical narrative: Muscle pain for the last two weeks
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute kidney injury, Asthenia, Blood creatinine increased, Blood culture negative, Blood thyroid stimulating hormone normal
Clinical narrative: Patient is a 77 y.o. male who presented from home on 9/17/2023 with falls and weakness ,found to be COVID positive.  Patient was not hypoxic, no need for steroid, antiviral therapies, continue supportive care, PT/OT for weakness and falls recommended skilled nursing therapy and sent to SNF.  Patient had acute kidney injury on CKD stage IV that resolved with IV hydration and temporarily hold lisinopril and restarted on 9/24.    COVID 19 Infection Generalized Weakness - Presented with: Weakness, fall - Symptom onset: Day of admission - Positive COVID-19: 9/17 at facility - Vaccination status: Vaccinated with Pfizer and boosted with Pfizer with booster dose on 11/2022 - CXR on admission showed borderline cardiomegaly, nonacute - Oxygen status: Room air - Decadron: Does not qualify due to SpO2>94% on RA. - Remdesivir: Does not qualify due to SpO2>94% on RA.  - DVT prophylaxis: Subcutaneous heparin - Serial COVID labs ordered: No, given no hypoxia - Case Management/Social Services consulted: Yes -Supportive care and physical therapy and Occupational Therapy.   AKI on CKD 4-resolved -Baseline creatinine of 1.9-2.5 -Cr worsened to 3.06 on 9/21 -He noted vomiting, and pre-syncope with hypotension yesterday -Appreciate nephrology Cr improving, no signed off -Resolved AKI with IVF and holding antiHTN meds -Resume lisinopril 9/24   Ischemic colitis Noted colitis on CT abd/pelvis from 9/20 -Suspect that this is ischemic over infectious or inflammatory.  Patient has had some hypotensive episodes and noted some bleeding.  -We will support blood pressure, check lactic acid and monitor abdominal pain -Less concerned for infection, blood cx ngtd, gi path panel cancelled per protocol  Frequent Falls Patient does need a walker at home at baseline.  Does not have any home health care services in place. Presented with falls at home.  -Likely with exacerbation of weakness due to COVID, with baseline gait impairment 2/2 MS and deconditioning -CT cervical spine, head, and maxillofacial scan showing no acute injury. -PT and OT evaluation -Orthostatic positive on 9/20, likely also with slowed baroreceptors -TSH and b12 not deficient   Essential HTN, uncontrolled  RAS - pt with uncontrolled HTN secondary to bilateral RAS. S/p stent to L renal artery on 5/18/22, right renal artery stent placed on 6/17/2022 -Has had hypotensive episodes: hold parameters on his Norvasc and Coreg -Resume lisinopril 9/24, continue to hold hydralazine  -Patient on aspirin Plavix, post stenting  -Continue to monitor   Diabetes mellitus type 2 with hyperglycemia  -Continue home Januvia 25 mg QD   MS - follows with Dr., OP follow up as scheduled  -Not on any biologic therapy or DMARDs. - uses 4 wheeled walker at baseline -Neurology consulted for concern for possible worsening MS with LUE weakness: recommended supportive care of MS.   Pulmonary HTN - mild, RVSP 40 mmHg
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cardiomegaly, Chest X-ray abnormal, Chronic kidney disease, Colitis ischaemic
Clinical narrative: Patient is a 77 y.o. male who presented from home on 9/17/2023 with falls and weakness ,found to be COVID positive.  Patient was not hypoxic, no need for steroid, antiviral therapies, continue supportive care, PT/OT for weakness and falls recommended skilled nursing therapy and sent to SNF.  Patient had acute kidney injury on CKD stage IV that resolved with IV hydration and temporarily hold lisinopril and restarted on 9/24.    COVID 19 Infection Generalized Weakness - Presented with: Weakness, fall - Symptom onset: Day of admission - Positive COVID-19: 9/17 at facility - Vaccination status: Vaccinated with Pfizer and boosted with Pfizer with booster dose on 11/2022 - CXR on admission showed borderline cardiomegaly, nonacute - Oxygen status: Room air - Decadron: Does not qualify due to SpO2>94% on RA. - Remdesivir: Does not qualify due to SpO2>94% on RA.  - DVT prophylaxis: Subcutaneous heparin - Serial COVID labs ordered: No, given no hypoxia - Case Management/Social Services consulted: Yes -Supportive care and physical therapy and Occupational Therapy.   AKI on CKD 4-resolved -Baseline creatinine of 1.9-2.5 -Cr worsened to 3.06 on 9/21 -He noted vomiting, and pre-syncope with hypotension yesterday -Appreciate nephrology Cr improving, no signed off -Resolved AKI with IVF and holding antiHTN meds -Resume lisinopril 9/24   Ischemic colitis Noted colitis on CT abd/pelvis from 9/20 -Suspect that this is ischemic over infectious or inflammatory.  Patient has had some hypotensive episodes and noted some bleeding.  -We will support blood pressure, check lactic acid and monitor abdominal pain -Less concerned for infection, blood cx ngtd, gi path panel cancelled per protocol  Frequent Falls Patient does need a walker at home at baseline.  Does not have any home health care services in place. Presented with falls at home.  -Likely with exacerbation of weakness due to COVID, with baseline gait impairment 2/2 MS and deconditioning -CT cervical spine, head, and maxillofacial scan showing no acute injury. -PT and OT evaluation -Orthostatic positive on 9/20, likely also with slowed baroreceptors -TSH and b12 not deficient   Essential HTN, uncontrolled  RAS - pt with uncontrolled HTN secondary to bilateral RAS. S/p stent to L renal artery on 5/18/22, right renal artery stent placed on 6/17/2022 -Has had hypotensive episodes: hold parameters on his Norvasc and Coreg -Resume lisinopril 9/24, continue to hold hydralazine  -Patient on aspirin Plavix, post stenting  -Continue to monitor   Diabetes mellitus type 2 with hyperglycemia  -Continue home Januvia 25 mg QD   MS - follows with Dr., OP follow up as scheduled  -Not on any biologic therapy or DMARDs. - uses 4 wheeled walker at baseline -Neurology consulted for concern for possible worsening MS with LUE weakness: recommended supportive care of MS.   Pulmonary HTN - mild, RVSP 40 mmHg
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram head normal, Computerised tomogram spine normal, Fall, Gait disturbance
Clinical narrative: Patient is a 77 y.o. male who presented from home on 9/17/2023 with falls and weakness ,found to be COVID positive.  Patient was not hypoxic, no need for steroid, antiviral therapies, continue supportive care, PT/OT for weakness and falls recommended skilled nursing therapy and sent to SNF.  Patient had acute kidney injury on CKD stage IV that resolved with IV hydration and temporarily hold lisinopril and restarted on 9/24.    COVID 19 Infection Generalized Weakness - Presented with: Weakness, fall - Symptom onset: Day of admission - Positive COVID-19: 9/17 at facility - Vaccination status: Vaccinated with Pfizer and boosted with Pfizer with booster dose on 11/2022 - CXR on admission showed borderline cardiomegaly, nonacute - Oxygen status: Room air - Decadron: Does not qualify due to SpO2>94% on RA. - Remdesivir: Does not qualify due to SpO2>94% on RA.  - DVT prophylaxis: Subcutaneous heparin - Serial COVID labs ordered: No, given no hypoxia - Case Management/Social Services consulted: Yes -Supportive care and physical therapy and Occupational Therapy.   AKI on CKD 4-resolved -Baseline creatinine of 1.9-2.5 -Cr worsened to 3.06 on 9/21 -He noted vomiting, and pre-syncope with hypotension yesterday -Appreciate nephrology Cr improving, no signed off -Resolved AKI with IVF and holding antiHTN meds -Resume lisinopril 9/24   Ischemic colitis Noted colitis on CT abd/pelvis from 9/20 -Suspect that this is ischemic over infectious or inflammatory.  Patient has had some hypotensive episodes and noted some bleeding.  -We will support blood pressure, check lactic acid and monitor abdominal pain -Less concerned for infection, blood cx ngtd, gi path panel cancelled per protocol  Frequent Falls Patient does need a walker at home at baseline.  Does not have any home health care services in place. Presented with falls at home.  -Likely with exacerbation of weakness due to COVID, with baseline gait impairment 2/2 MS and deconditioning -CT cervical spine, head, and maxillofacial scan showing no acute injury. -PT and OT evaluation -Orthostatic positive on 9/20, likely also with slowed baroreceptors -TSH and b12 not deficient   Essential HTN, uncontrolled  RAS - pt with uncontrolled HTN secondary to bilateral RAS. S/p stent to L renal artery on 5/18/22, right renal artery stent placed on 6/17/2022 -Has had hypotensive episodes: hold parameters on his Norvasc and Coreg -Resume lisinopril 9/24, continue to hold hydralazine  -Patient on aspirin Plavix, post stenting  -Continue to monitor   Diabetes mellitus type 2 with hyperglycemia  -Continue home Januvia 25 mg QD   MS - follows with Dr., OP follow up as scheduled  -Not on any biologic therapy or DMARDs. - uses 4 wheeled walker at baseline -Neurology consulted for concern for possible worsening MS with LUE weakness: recommended supportive care of MS.   Pulmonary HTN - mild, RVSP 40 mmHg
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Haemorrhage, Hyperglycaemia, Hypotension, Muscular weakness, Physical deconditioning
Clinical narrative: Patient is a 77 y.o. male who presented from home on 9/17/2023 with falls and weakness ,found to be COVID positive.  Patient was not hypoxic, no need for steroid, antiviral therapies, continue supportive care, PT/OT for weakness and falls recommended skilled nursing therapy and sent to SNF.  Patient had acute kidney injury on CKD stage IV that resolved with IV hydration and temporarily hold lisinopril and restarted on 9/24.    COVID 19 Infection Generalized Weakness - Presented with: Weakness, fall - Symptom onset: Day of admission - Positive COVID-19: 9/17 at facility - Vaccination status: Vaccinated with Pfizer and boosted with Pfizer with booster dose on 11/2022 - CXR on admission showed borderline cardiomegaly, nonacute - Oxygen status: Room air - Decadron: Does not qualify due to SpO2>94% on RA. - Remdesivir: Does not qualify due to SpO2>94% on RA.  - DVT prophylaxis: Subcutaneous heparin - Serial COVID labs ordered: No, given no hypoxia - Case Management/Social Services consulted: Yes -Supportive care and physical therapy and Occupational Therapy.   AKI on CKD 4-resolved -Baseline creatinine of 1.9-2.5 -Cr worsened to 3.06 on 9/21 -He noted vomiting, and pre-syncope with hypotension yesterday -Appreciate nephrology Cr improving, no signed off -Resolved AKI with IVF and holding antiHTN meds -Resume lisinopril 9/24   Ischemic colitis Noted colitis on CT abd/pelvis from 9/20 -Suspect that this is ischemic over infectious or inflammatory.  Patient has had some hypotensive episodes and noted some bleeding.  -We will support blood pressure, check lactic acid and monitor abdominal pain -Less concerned for infection, blood cx ngtd, gi path panel cancelled per protocol  Frequent Falls Patient does need a walker at home at baseline.  Does not have any home health care services in place. Presented with falls at home.  -Likely with exacerbation of weakness due to COVID, with baseline gait impairment 2/2 MS and deconditioning -CT cervical spine, head, and maxillofacial scan showing no acute injury. -PT and OT evaluation -Orthostatic positive on 9/20, likely also with slowed baroreceptors -TSH and b12 not deficient   Essential HTN, uncontrolled  RAS - pt with uncontrolled HTN secondary to bilateral RAS. S/p stent to L renal artery on 5/18/22, right renal artery stent placed on 6/17/2022 -Has had hypotensive episodes: hold parameters on his Norvasc and Coreg -Resume lisinopril 9/24, continue to hold hydralazine  -Patient on aspirin Plavix, post stenting  -Continue to monitor   Diabetes mellitus type 2 with hyperglycemia  -Continue home Januvia 25 mg QD   MS - follows with Dr., OP follow up as scheduled  -Not on any biologic therapy or DMARDs. - uses 4 wheeled walker at baseline -Neurology consulted for concern for possible worsening MS with LUE weakness: recommended supportive care of MS.   Pulmonary HTN - mild, RVSP 40 mmHg
Age: 76.0
Sex: M
Vaccine: COVID19-2
Symptoms: Presyncope, Pulmonary hypertension, SARS-CoV-2 test positive, Vitamin B12 normal, Vomiting
Clinical narrative: Patient is a 77 y.o. male who presented from home on 9/17/2023 with falls and weakness ,found to be COVID positive.  Patient was not hypoxic, no need for steroid, antiviral therapies, continue supportive care, PT/OT for weakness and falls recommended skilled nursing therapy and sent to SNF.  Patient had acute kidney injury on CKD stage IV that resolved with IV hydration and temporarily hold lisinopril and restarted on 9/24.    COVID 19 Infection Generalized Weakness - Presented with: Weakness, fall - Symptom onset: Day of admission - Positive COVID-19: 9/17 at facility - Vaccination status: Vaccinated with Pfizer and boosted with Pfizer with booster dose on 11/2022 - CXR on admission showed borderline cardiomegaly, nonacute - Oxygen status: Room air - Decadron: Does not qualify due to SpO2>94% on RA. - Remdesivir: Does not qualify due to SpO2>94% on RA.  - DVT prophylaxis: Subcutaneous heparin - Serial COVID labs ordered: No, given no hypoxia - Case Management/Social Services consulted: Yes -Supportive care and physical therapy and Occupational Therapy.   AKI on CKD 4-resolved -Baseline creatinine of 1.9-2.5 -Cr worsened to 3.06 on 9/21 -He noted vomiting, and pre-syncope with hypotension yesterday -Appreciate nephrology Cr improving, no signed off -Resolved AKI with IVF and holding antiHTN meds -Resume lisinopril 9/24   Ischemic colitis Noted colitis on CT abd/pelvis from 9/20 -Suspect that this is ischemic over infectious or inflammatory.  Patient has had some hypotensive episodes and noted some bleeding.  -We will support blood pressure, check lactic acid and monitor abdominal pain -Less concerned for infection, blood cx ngtd, gi path panel cancelled per protocol  Frequent Falls Patient does need a walker at home at baseline.  Does not have any home health care services in place. Presented with falls at home.  -Likely with exacerbation of weakness due to COVID, with baseline gait impairment 2/2 MS and deconditioning -CT cervical spine, head, and maxillofacial scan showing no acute injury. -PT and OT evaluation -Orthostatic positive on 9/20, likely also with slowed baroreceptors -TSH and b12 not deficient   Essential HTN, uncontrolled  RAS - pt with uncontrolled HTN secondary to bilateral RAS. S/p stent to L renal artery on 5/18/22, right renal artery stent placed on 6/17/2022 -Has had hypotensive episodes: hold parameters on his Norvasc and Coreg -Resume lisinopril 9/24, continue to hold hydralazine  -Patient on aspirin Plavix, post stenting  -Continue to monitor   Diabetes mellitus type 2 with hyperglycemia  -Continue home Januvia 25 mg QD   MS - follows with Dr., OP follow up as scheduled  -Not on any biologic therapy or DMARDs. - uses 4 wheeled walker at baseline -Neurology consulted for concern for possible worsening MS with LUE weakness: recommended supportive care of MS.   Pulmonary HTN - mild, RVSP 40 mmHg
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Hand dermatitis
Clinical narrative: Eczema, began two days after vaccination on 9/22/2023, spread and covering entire body (elbows, knees, buttocks, thighs, calves, hands, forearms, patches on back, spots on feet, spots on upper and inner arms) as of 10/18/2023 ongoing and being treated by topical steroid as well as over-the-counter remedies
Age: 12.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Given 5-11 yr vaccine instead of 12 yr and older vaccine No adverse events.  Parent contacted when error was discovered
Age: 15.0
Sex: F
Vaccine: HPV9
Symptoms: Abdominal discomfort, Chills, Diarrhoea, Fatigue, Loss of personal independence in daily activities
Clinical narrative: Mom reported that Pt. woke up with itchy elbows, rash on face, arms, chest torso, chills, tired. Her arm was also sore. She only had a slight local reaction at vaccine site due to the bandaide. Mom describes the rash as similar to prickly heat. Temperature was not taken. Mom applied Cortisone Cream listed previously twice and the itching improved. Rash resolved over one week ago --a few days after the vaccine was given. Pt. has had GI upset and diarrhea x 6 on 10/13/23. She also complains of nausea and has not been back to school yet.
Age: 15.0
Sex: F
Vaccine: HPV9
Symptoms: Nausea, Pain in extremity, Pruritus, Rash, Skin warm
Clinical narrative: Mom reported that Pt. woke up with itchy elbows, rash on face, arms, chest torso, chills, tired. Her arm was also sore. She only had a slight local reaction at vaccine site due to the bandaide. Mom describes the rash as similar to prickly heat. Temperature was not taken. Mom applied Cortisone Cream listed previously twice and the itching improved. Rash resolved over one week ago --a few days after the vaccine was given. Pt. has had GI upset and diarrhea x 6 on 10/13/23. She also complains of nausea and has not been back to school yet.
Age: 15.0
Sex: F
Vaccine: HPV9
Symptoms: Vaccination site reaction
Clinical narrative: Mom reported that Pt. woke up with itchy elbows, rash on face, arms, chest torso, chills, tired. Her arm was also sore. She only had a slight local reaction at vaccine site due to the bandaide. Mom describes the rash as similar to prickly heat. Temperature was not taken. Mom applied Cortisone Cream listed previously twice and the itching improved. Rash resolved over one week ago --a few days after the vaccine was given. Pt. has had GI upset and diarrhea x 6 on 10/13/23. She also complains of nausea and has not been back to school yet.
Age: 80.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Flushing, Headache, Petechiae, Rash, Vomiting
Clinical narrative: rash to face, petechia to face, flushed, vomiting, headache
Age: 42.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Dizziness, Dysgeusia, Feeling abnormal
Clinical narrative: Within 1 minute of injection, patient stated he had funny taste in mouth like sweet antifreeze, also felt funny, lightheaded and strange feeling.   BP was taken 155/99, AP-69, O2 Sat. 98%.  Gave pt. some water and a cracker since he stated earlier he did not like needles. Patient stated he has never felt like this after vaccine injection.  After 5-10 minutes, symptoms began to improve.  Pt. stayed with writer 15-20 minutes and then stated he felt okay to leave, he had another appt. at clinic today.  Final BP 133/87, AP-68, O2 Sat. 98% before released.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Varicella, live vaccine was completed on 9/22/23 just after live MMR vaccine was given on 9/19/23
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product use issue
Clinical narrative: this patient's family arrived at the Respiratory Clinic for their annual flu shot and they decided to also get the Moderna vaccine added on for all three family members.  While this patient's age showed she was eligible for the vaccine, we learned _after_ giving the vaccine that they had previously received doses of the Pfizer vaccine for their age group on 09/08/22, 11/03/22 and 04/20/23.  It was after injecting this patient with the Moderna monovalent, database informed us that this patient was not eligible to receive the Moderna vaccine based on the fact that they previously had been caught up with the Pfizer dose.  Patient's mother was instructed to wait 15 minutes for observation and nothing out of the norm occurred. I wanted to let you know that this happened in the event that your team would like to do any follow up.  PCP, Dr. has been notified of this incident. I am also filing a Data and VAERS report regarding this incident.
Age: 8.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Chest pain, Electrocardiogram, Nausea, Pyrexia, Rhinorrhoea
Clinical narrative: Chest pain, fever, runny nose, nausea
Age: 30.0
Sex: F
Vaccine: FLU4
Symptoms: Hyperhidrosis, Hypotension, Presyncope
Clinical narrative: Vasovagal response, hypotension (70/30), diaphoretic but responsive.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Blood culture negative, COVID-19
Clinical narrative: Patient is a 82 y.o. male with a history of Hypothyroidism, BPH, Anxiety, and Osteoarthritis who presented to RMH 9/23/2023 with worsening shortness of breath for 2 days after he tested positive for COVID. In ED: required BiPap.     1. COVID-19: Vaccinated, on Paxlovid prior to admission. Symptoms started on 9/19/23 (3 days prior to admission). SARS-CoV-2 positive on 9/20/23. CXR 9/23/23: non-acute. Blood cultures 9/23/23: no growth to date. CT chest 9/25/23 seems more consistent with bilateral lower lobe pneumonia and pulm started CAP abxs as bellow. Supportive care. Weaned off oxygen 9/29/23. No need for further steroids. Isolation completed 9/30/23. 2. Acute Hypoxic Respiratory Failure: Not on oxygen prior to admission, required BiPap 18/10 in ED due to above, weaned to HHF on 9/23/3034. CTPA 9/25/23 with small segmental PE and concern for consolidations RLL worse than LLL. Anticoagulation started, abx started. Home o2 eval 9/29/23 and weaned to RA.  3. CAP: Per ct as above. Rocephin azithro started. Abx through 10/1/23 transitioned to omnicef on discharge. 4. Pulmonary embolism: In setting of covid and pneumonia. LEVD negative. Heparin gtt started, transitioned to eliquis 9/27/23. Continue for 3 months for provoked PE in setting of COVID.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest X-ray normal, Computerised tomogram thorax abnormal, Dyspnoea, Pneumonia, Positive airway pressure therapy
Clinical narrative: Patient is a 82 y.o. male with a history of Hypothyroidism, BPH, Anxiety, and Osteoarthritis who presented to RMH 9/23/2023 with worsening shortness of breath for 2 days after he tested positive for COVID. In ED: required BiPap.     1. COVID-19: Vaccinated, on Paxlovid prior to admission. Symptoms started on 9/19/23 (3 days prior to admission). SARS-CoV-2 positive on 9/20/23. CXR 9/23/23: non-acute. Blood cultures 9/23/23: no growth to date. CT chest 9/25/23 seems more consistent with bilateral lower lobe pneumonia and pulm started CAP abxs as bellow. Supportive care. Weaned off oxygen 9/29/23. No need for further steroids. Isolation completed 9/30/23. 2. Acute Hypoxic Respiratory Failure: Not on oxygen prior to admission, required BiPap 18/10 in ED due to above, weaned to HHF on 9/23/3034. CTPA 9/25/23 with small segmental PE and concern for consolidations RLL worse than LLL. Anticoagulation started, abx started. Home o2 eval 9/29/23 and weaned to RA.  3. CAP: Per ct as above. Rocephin azithro started. Abx through 10/1/23 transitioned to omnicef on discharge. 4. Pulmonary embolism: In setting of covid and pneumonia. LEVD negative. Heparin gtt started, transitioned to eliquis 9/27/23. Continue for 3 months for provoked PE in setting of COVID.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pulmonary embolism, SARS-CoV-2 test positive
Clinical narrative: Patient is a 82 y.o. male with a history of Hypothyroidism, BPH, Anxiety, and Osteoarthritis who presented to RMH 9/23/2023 with worsening shortness of breath for 2 days after he tested positive for COVID. In ED: required BiPap.     1. COVID-19: Vaccinated, on Paxlovid prior to admission. Symptoms started on 9/19/23 (3 days prior to admission). SARS-CoV-2 positive on 9/20/23. CXR 9/23/23: non-acute. Blood cultures 9/23/23: no growth to date. CT chest 9/25/23 seems more consistent with bilateral lower lobe pneumonia and pulm started CAP abxs as bellow. Supportive care. Weaned off oxygen 9/29/23. No need for further steroids. Isolation completed 9/30/23. 2. Acute Hypoxic Respiratory Failure: Not on oxygen prior to admission, required BiPap 18/10 in ED due to above, weaned to HHF on 9/23/3034. CTPA 9/25/23 with small segmental PE and concern for consolidations RLL worse than LLL. Anticoagulation started, abx started. Home o2 eval 9/29/23 and weaned to RA.  3. CAP: Per ct as above. Rocephin azithro started. Abx through 10/1/23 transitioned to omnicef on discharge. 4. Pulmonary embolism: In setting of covid and pneumonia. LEVD negative. Heparin gtt started, transitioned to eliquis 9/27/23. Continue for 3 months for provoked PE in setting of COVID.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: VACCINE WAS STORD IN AN UNAPPROVED STORAGE UNIT
Age: 32.0
Sex: F
Vaccine: PNC20
Symptoms: Expired product administered, No adverse event
Clinical narrative: the patient had no reactions to this  the med was expired
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anticoagulant therapy, Asthenia, Bladder catheterisation, Bladder injury
Clinical narrative: Patient is a 90 y.o. female who presented from home on 9/11/2023 with weakness, fever, found to have covid and acute on chronic HFpEF. Placed on steroids, remdesivir and IV lasix, weaned off O2. PT/OT evaluated, patient elected for SNF on DC.    Acute hypoxic respiratory failure, resolved COVID-19 -Presented with: fevers and generalized weakness -Symptom onset: 9/10/2023 -Positive COVID-19: 9/11/2023 at Hospital -Vaccination status: Vaccinated with Moderna with last dose 4/29/2022 -CTPE on admission showed NO PE. Bilateral effusions with mild backround interstitial edema, reactive LN in the mediastinum. -Oxygen status: 2-3 liters -> 1L-> RA 9/15 -Decadron: Yes. Stopped on discharge as off o2 -Remdesivir: Yes. completed -DVT prophylaxis: Currently on full anticoagulation -Case Management/Social Services consulted: Yes    Thrombocytopenia  -likely from covid. Hemolysis labs negative. Smear not concerning starting to improve -improvin   Hyponatremia -History of SIADH with chronically low sodium around 130 (was 127 per labs July 2023) -note Na drop on 9/14, asymptomatic. Improved with salt tabs while here, resumption of diurtics   Acute on chronic diastolic heart failure, acute failure resolved Severe Mitral Regurgitation Pulmonary hypertension -Home medications are: torsemide 20 mg daily, with dry weight of 105 pounds, Toprol 25 mg daily, and cozaar. -Echo 7/20/2023 showed EF 50 and severe MR  -Despite being at normal weight, she still has signs of acute CHF ie. CT chest findings, SOB, etc -s/p lasix 40 mg IV BID, strict I/Os. IV lasix as above, resumed torsemide 9/15 -Continue with Toprol and cozaar.   Urinary retention -presumably from acute illness/ decreased mobility. Developed likely stretch injury to bladder with > 1 liter -foley placed 9/12, can plan on voiding trial in 7-10 days   Elevated LFTs -likely from covid, were nml may 2023 -monitor, can resume statin in two weeks   Persistent atrial fibrillation -HR is stable -Continue Eliquis and Toprol-XL Rheumatoid arthritis -Home meds are prednisone 5 mg daily and plaquenil 200 mg daily -Continue with decadron per COVID. held home plaquenil, resume on dc   Essential hypertension -Home medications include: Toprol-XL, losartan, torsemide. -Continue home Toprol-XL and losartan.     Hypothyroidism -Continue with Synthroid   Generalized Anxiety Major Depression in remission -Continue Celexa   Hyperlipidemia -holding statin as above   GERD -Continue with PPI
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Blood sodium decreased, COVID-19, Cardiac failure acute, Cardiac failure congestive, Computerised tomogram thorax abnormal
Clinical narrative: Patient is a 90 y.o. female who presented from home on 9/11/2023 with weakness, fever, found to have covid and acute on chronic HFpEF. Placed on steroids, remdesivir and IV lasix, weaned off O2. PT/OT evaluated, patient elected for SNF on DC.    Acute hypoxic respiratory failure, resolved COVID-19 -Presented with: fevers and generalized weakness -Symptom onset: 9/10/2023 -Positive COVID-19: 9/11/2023 at Hospital -Vaccination status: Vaccinated with Moderna with last dose 4/29/2022 -CTPE on admission showed NO PE. Bilateral effusions with mild backround interstitial edema, reactive LN in the mediastinum. -Oxygen status: 2-3 liters -> 1L-> RA 9/15 -Decadron: Yes. Stopped on discharge as off o2 -Remdesivir: Yes. completed -DVT prophylaxis: Currently on full anticoagulation -Case Management/Social Services consulted: Yes    Thrombocytopenia  -likely from covid. Hemolysis labs negative. Smear not concerning starting to improve -improvin   Hyponatremia -History of SIADH with chronically low sodium around 130 (was 127 per labs July 2023) -note Na drop on 9/14, asymptomatic. Improved with salt tabs while here, resumption of diurtics   Acute on chronic diastolic heart failure, acute failure resolved Severe Mitral Regurgitation Pulmonary hypertension -Home medications are: torsemide 20 mg daily, with dry weight of 105 pounds, Toprol 25 mg daily, and cozaar. -Echo 7/20/2023 showed EF 50 and severe MR  -Despite being at normal weight, she still has signs of acute CHF ie. CT chest findings, SOB, etc -s/p lasix 40 mg IV BID, strict I/Os. IV lasix as above, resumed torsemide 9/15 -Continue with Toprol and cozaar.   Urinary retention -presumably from acute illness/ decreased mobility. Developed likely stretch injury to bladder with > 1 liter -foley placed 9/12, can plan on voiding trial in 7-10 days   Elevated LFTs -likely from covid, were nml may 2023 -monitor, can resume statin in two weeks   Persistent atrial fibrillation -HR is stable -Continue Eliquis and Toprol-XL Rheumatoid arthritis -Home meds are prednisone 5 mg daily and plaquenil 200 mg daily -Continue with decadron per COVID. held home plaquenil, resume on dc   Essential hypertension -Home medications include: Toprol-XL, losartan, torsemide. -Continue home Toprol-XL and losartan.     Hypothyroidism -Continue with Synthroid   Generalized Anxiety Major Depression in remission -Continue Celexa   Hyperlipidemia -holding statin as above   GERD -Continue with PPI
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Diuretic therapy, Dyspnoea, Echocardiogram abnormal, Hyponatraemia, Illness
Clinical narrative: Patient is a 90 y.o. female who presented from home on 9/11/2023 with weakness, fever, found to have covid and acute on chronic HFpEF. Placed on steroids, remdesivir and IV lasix, weaned off O2. PT/OT evaluated, patient elected for SNF on DC.    Acute hypoxic respiratory failure, resolved COVID-19 -Presented with: fevers and generalized weakness -Symptom onset: 9/10/2023 -Positive COVID-19: 9/11/2023 at Hospital -Vaccination status: Vaccinated with Moderna with last dose 4/29/2022 -CTPE on admission showed NO PE. Bilateral effusions with mild backround interstitial edema, reactive LN in the mediastinum. -Oxygen status: 2-3 liters -> 1L-> RA 9/15 -Decadron: Yes. Stopped on discharge as off o2 -Remdesivir: Yes. completed -DVT prophylaxis: Currently on full anticoagulation -Case Management/Social Services consulted: Yes    Thrombocytopenia  -likely from covid. Hemolysis labs negative. Smear not concerning starting to improve -improvin   Hyponatremia -History of SIADH with chronically low sodium around 130 (was 127 per labs July 2023) -note Na drop on 9/14, asymptomatic. Improved with salt tabs while here, resumption of diurtics   Acute on chronic diastolic heart failure, acute failure resolved Severe Mitral Regurgitation Pulmonary hypertension -Home medications are: torsemide 20 mg daily, with dry weight of 105 pounds, Toprol 25 mg daily, and cozaar. -Echo 7/20/2023 showed EF 50 and severe MR  -Despite being at normal weight, she still has signs of acute CHF ie. CT chest findings, SOB, etc -s/p lasix 40 mg IV BID, strict I/Os. IV lasix as above, resumed torsemide 9/15 -Continue with Toprol and cozaar.   Urinary retention -presumably from acute illness/ decreased mobility. Developed likely stretch injury to bladder with > 1 liter -foley placed 9/12, can plan on voiding trial in 7-10 days   Elevated LFTs -likely from covid, were nml may 2023 -monitor, can resume statin in two weeks   Persistent atrial fibrillation -HR is stable -Continue Eliquis and Toprol-XL Rheumatoid arthritis -Home meds are prednisone 5 mg daily and plaquenil 200 mg daily -Continue with decadron per COVID. held home plaquenil, resume on dc   Essential hypertension -Home medications include: Toprol-XL, losartan, torsemide. -Continue home Toprol-XL and losartan.     Hypothyroidism -Continue with Synthroid   Generalized Anxiety Major Depression in remission -Continue Celexa   Hyperlipidemia -holding statin as above   GERD -Continue with PPI